期刊文献+

重组白细胞介素17F对肺炎支原体感染小鼠体内防御素β-2及巨噬细胞炎性蛋白表达的影响 被引量:2

Effects of Recombinant Interleukin 17F on Expressions of β-Defensin-2 and Macrophage Inflammatory Protein in Murine Mycoplasma Pneumoniae Infection Mice
原文传递
导出
摘要 目的观察重组白细胞介素17F(rIL-17F)对肺炎支原体(MP)感染小鼠体内防御素β-2(Defb-2)及巨噬细胞炎性蛋白(MIP)表达的影响,探讨rIL-17F防御MP感染的相关机制。方法 SPF级BALB/c小鼠随机分为感染组、干预组和对照组,以鼻腔接种的方式建立MP感染模型,以鼻腔黏膜免疫方式进行rIL-17F干预。采用荧光定量PCR法检测其肺组织Defb-2、MIP-1α、MIP-2βmRNA的表达水平,ELISA法检测其肺泡灌洗液(BALF)、脾脏及纵隔淋巴结细胞培养上清中MIP-1α、MIP-2β、IL-4、IFN-γ水平。结果 1.干预组MP菌落计数明显低于感染组,BALF中白细胞总数及中性粒细胞、巨噬细胞计数明显高于感染组,差异均有统计学意义。对照组无菌落生长。感染组BALF中白细胞总数及中性粒细胞、巨噬细胞计数明显高于对照组,差异均有统计学意义。2.干预组肺组织Defb-2、MIP-1α和MIP-2βmRNA表达水平均明显高于感染组,差异有统计学意义。3.干预组与感染组比较,MIP-1α水平在纵隔淋巴结细胞培养上清中明显升高,MIP-2β水平在BALF和纵隔淋巴结细胞培养上清中明显升高,差异均有统计学意义;IL-4水平在BALF中明显降低,在脾细胞培养上清中则明显升高,差异均有统计学意义;IFN-γ水平在脾细胞培养上清中明显升高,差异有统计学意义。感染组与对照组比较,MIP-1α水平在脾细胞及纵隔淋巴结细胞培养上清中均明显升高,差异有统计学意义;MIP-2β水平两组之间无显著差异;IL-4水平在BALF及脾细胞培养上清中均明显升高,差异有统计学意义;IFN-γ水平在BALF中明显升高,差异有统计学意义。结论 rIL-17F能促进Defb-2及MIP等炎性因子的表达,调节Th1/Th2平衡,增加感染部位中性粒细胞和巨噬细胞等炎性细胞的聚集,提高MP清除率,增强机体抗感染能力。 Objective To evaluate the effects of recombinant interleukin- 17F( rIL- 17F) on expressions of β -defensin-2 (Defb- 2) and macrophage inflammatory protein (MIP) in murine mycoplasma pneumoniae(MP) infection mice. Methods BALB/c mice were di- vided randomly into MP infection group, rIL - 17F intervention group and control group. Before intranasal infection with MP, the mice were treated with phosphate buffered solution or rIL - 17F, respectively. The numbers of bacteria and leukoeytes in bronchoalveolar lavage fluid (BALF) were counted,and the mRNA levels of Defb -2, MIP - 1α and MIP -2β in lung tissue were detected by real -time fluorescent quantitative polymerase chain reaction, the concentrations of MIP - 1 a, MIP - 2β, IL - 4 and IFN - 3' in BALF, supernatants of spleen cell and mediastinal lymph node cell were assayed by enzyme linked immunosorbent assay. Results 1. Compared with the infection group,the neutro- phil and maerophage numbers in BALF were higher in intervention group, while the number of bacteria was lower. There was no bacteria in control group. Compared with the control group, the nentrophil and macrophage numbers in BALF were higher in infection group. 2. Compared with infection group,the mRNA expression levels of Defb -2, MIP - 1α and MIP -2β in lung tissue were higher in intervention group. 3. Compared with infection group, the level of MIP - 1α in lymph node cell culture supernatants was higher in intervention group;The levels of MIP -2β in BALF and lymph node cell culture supernatants were higher in intervention group;The level of IL -4 was lower in BALF in intervention group, while higher level of IL -4 was detected in spleen cell culture supernatants ;The level of IFN - 3' in spleen cell culture superna- tants was higher in intervention group. Compared with control group, the level of MIP - 1 α in spleen cell and lymph node cell culture superna- tants was higher in infection group; There was no significant difference in the level of MIP -2β between 2 groups;The level of IL- 4 was higher in BALF and spleen cell culture supernatants in infection group ; The level of fEN - 3' in BALF was higher in infection group. Conclu- sions Intranasal inoculation of rlL - 17F can promote pulmonary neutrophil and macrophage recruitment and increase bacterium clearance, enhance the host defense against MP infection through increasing the expression levels of defensins, MIP and regulating Thl/Th2 balance.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2012年第9期665-667,702,共4页 Journal of Applied Clinical Pediatrics
基金 上海市自然科学基金资助项目(10ZR1423000)
关键词 白细胞介素17F 肺炎支原体 防御素β-2 巨噬细胞炎性蛋白 interleukin - 17F mycoplasma pneumoniae 13 - defensin - 2 macrophage inflammatory protein
  • 相关文献

参考文献15

  • 1Kicinski P,Wisniewska-Ligier M,Wozniakowska-Gesicka T. Pneumonia caused by mycoplasma pneumoniae and chlamydophila pneumoniae in children-comparative analysis of clinical picture[J].Adv Med Sci,2011,(01):56-63.
  • 2Defilippi A,Silvestri M,Tacchella A. Epidemiology and clinical features of mycoplasma pneumoniae infection in children[J].Respiratory Medicine,2008,(12):1762-1768.
  • 3Liu Y,Chen M,Zhao T. Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population[J].BMC Infectious Diseases,2009.31.
  • 4Wu Q,Martin RJ,Rino JG. IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory mycoplasma pneumoniae infection[J].Microbes and Infection,2007,(01):78-86.
  • 5Sieve AN,Meeks KD,Bodhankar S. A novel IL-17-dependent mechanism of cross protection:Respiratory infection with mycoplasma protects against a secondary listeria infection[J].European Journal of Immunology,2009,(02):426-438.
  • 6Jansen PA,Rodijk-Olthuis D,Hollox EJ. Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin[J].PLoS One,2009,(03):e4725.doi:10.1371/journal.pone.0004725.
  • 7Kao CY,Chen Y,Thai P. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways[J].Journal of Immunology,2004,(05):3482-3491.
  • 8Miyamoto M,Prause O,Sj(o)strand M. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways[J].Journal of Immunology,2003,(09):4665-4672.
  • 9董晓艳,陆权.小儿肺炎支原体感染的诊治现状与进展[J].实用儿科临床杂志,2011,26(4):235-238. 被引量:119
  • 10马红秋,李黎,徐雍,马少杰,辛德莉.肺炎支原体肺炎患儿免疫功能变化及匹多莫德对其治疗作用[J].实用儿科临床杂志,2010,25(22):1703-1704. 被引量:20

二级参考文献51

  • 1刘恩梅,王莉佳,罗蓉,杨锡强.匹多莫德影响小儿辅助T细胞亚群功能的体外研究[J].儿科药学杂志,2004,10(5):1-2. 被引量:32
  • 2林海燕.匹多莫德口服液治疗小儿反复呼吸道感染临床探讨[J].临床医学,2007,27(6):58-59. 被引量:8
  • 3陆权,车大钿.肺炎支原体感染诊治中的若干问题[J].国际儿科学杂志,2007,34(4):235-238. 被引量:60
  • 4抗菌药物临床试验技术指导原则[EB/OL].2^nd ed.www.cncro.com/newsdedail_4470.html.
  • 5Nolevaux G, Bessaci - Kabouya K, Villenet N, et al. Epidemiological and clinical study of mycoplasma pneumoniae respiratory infections in children hospitalized in a pediatric ward between 1999 and 2005 at the Reims University Hospital [ J ]. Arch Pediatr, 2008,15 ( 11 ) : 1630 - 1636.
  • 6Xin DE, Mi Z, Qin L, et al. Molecular mechanisms of macrolide resistance in clinical isolates of mycoplasma pneumoniae from China [ J ]. Antimicrob Agents Chemother ,2009 ,53 ( 5 ) :2158 - 2159.
  • 7Wolff B J, Thacker WL, Schwartz BS, et al. Detection of macrolide resistance in mycoplasma pneumoniae by real - time PCR and highresolution melt analysis [ J ]. Antimicrob Agents Chemother, 2008,52 ( 10 ) : 3542 - 3549.
  • 8Okazaki N, Ohya H, Sasaki T. Mycoplasma pneumoniae isolated from patients with respiratory infection in Kanagawa Prefecture in 1976 - 2006 : Emergence of macrolide - resistant strains [ J ]. Jpn J Infect Dis ,2007,60(5 ) :325 - 326.
  • 9Lee KY. Pediatric respiratory infections by Mycoplasma pneumoniae [ J]. Expert Rev Anti Infect Ther,2008,6(4) :509 -521.
  • 10Kim MS, Kilgore PE, Kang JS. Transient acquired hemophilia associated with Mycoplasma pneumoniae pneumonia [ J ]. J Korean Med Sci, 2008,23 ( 1 ) : 138 - 141.

共引文献137

同被引文献22

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部